Public Company Roundup: AmSurg, NovaMed and Medical Facilities Corp.

Here are some key financial statistics for AmSurg, NovaMed and Medical Facilities Corp.

Advertisement

AmSurg
Profitability
Profit margin (ttm): 7.83 percent
Operating margin (ttm): 35.04 percent

Income statement
Revenue (ttm): $600.66M
Revenue per share (ttm): $19.07
Gross Profit (ttm): $427.07M
EBITDA (ttm): $231.34M

Balance sheet
Total cash (mrq): $34.55M
Total cash per share (mrq): $1.10
Total debt (mrq): $272.64M

Stock price history

52-week change: -32.25 percent
52-week high (19-Sep-08): $28.93
52-week low (03-Mar-09): $12.23
50-day moving average: $16.35
200-day moving average: $20.89

NovaMed
Profitability
Profit margin (ttm): 6.78 percent
Operating margin (ttm): 25.41%

Income statement
Revenue (ttm): $141.22M
Revenue per share (ttm): $5.81
Gross profit (ttm): $65.97M
EBITDA (ttm): $40.20M

Balance sheet
Total cash (mrq): $1.77M
Total cash per share (mrq): $0.08
Total debt (mrq): $144.20M
       
Stock price history
52-week change: -39.74 percent
52-week high (22-Sep-08): $5.01
52-week low (12-Mar-09): $1.77
50-day moving average: $2.37
200-day moving average: $3.22

Medical Facilities Corp.
Profitability
Profit margin (ttm): 24.11 percent
Operating margin (ttm): 27.51 percent

Income statement

Revenue (2008): $199.38M
Gross profit (2008): $156.38M

Balance sheet
Total cash (2008): $25.74M
Total debt (2008): $286.16M

Stock price history
52-week change: -33.54 percent
52–week high (02-April-2008): $11.20 
52-week low (10-Oct-2008): $5.15

Source: Capital IQ, a division of Standard & Poor’s and company annual reports.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.